Fierce Pharma Asia—Trump’s generic drug tariffs; Samsung Bio’s $1.8B acquisition; An unusual IPO
Generic drugmakers will face import tariffs in the U.S., President Donald Trump announced this week. Samsung Biologics is…
Browsing Tag